NASDAQ: ANIX - Anixa Biosciences, Inc.

Lønnsomhet i seks måneder: -2.48%
Utbytte: 0.00%
Sektor: Healthcare

Kampanjeplan Anixa Biosciences, Inc.

Avansert tidsplan Enkel graf
Financial Markets by TradingView

Om selskapet Anixa Biosciences, Inc.

Anixa Biosciences, Inc., a biotechnology company, develops therapies and vaccines focusing on critical unmet needs in oncology and infectious diseases. The company's therapeutics programs include the development of a chimeric endocrine receptor T-cell therapy, a novel form of chimeric antigen receptor T-cell (CAR-T) technology focusing on the treatment of ovarian cancer; and the development of anti-viral drug candidates for the treatment of COVID-19 focused on inhibiting certain protein functions of the virus.

flere detaljer
Its vaccine programs comprise the development of a vaccine against triple negative breast cancer; and a preventative vaccine against ovarian cancer. The company is also developing immuno-therapy drugs against cancer. The company was formerly known as ITUS Corporation and changed its name to Anixa Biosciences, Inc. in October 2018. Anixa Biosciences, Inc. was incorporated in 1982 and is based in San Jose, California.
Legg til i sammenligningslisten
Legg til overvåkningsliste
Legg til portefølje
Legg til prisvarsel

IPO date 1987-01-01
ISIN US03528H1095
Industry Biotechnology
Sector Health Care
Валюта usd
Валюта отчета usd
Сайт https://www.anixa.com
Цена ао 3.05
Prisendring per dag: +2.61% (3.07)
Prisendring per uke: +2.27% (3.08)
Prisendring per måned: +5% (3)
Prisendring over 3 måneder: -4.55% (3.3)
Prisendring over seks måneder: -2.48% (3.23)
Prisendring per år: -10.26% (3.51)
Prisendring over 3 år: +18.42% (2.66)
Prisendring over 5 år: -11.27% (3.55)
Prisendring over 10 år: 0% (3.15)
Prisendring siden begynnelsen av året: +35.78% (2.32)
Alle parametere

Undervurdering

Navn Betydning Karakter
P/S 470.6 1
P/BV 6.7 1
P/E 0 0
EV/EBITDA -9.08 0
Total: 2.13

Effektivitet

Navn Betydning Karakter
ROA, % -53.29 0
ROE, % -56.63 0
Total: 0

Utbytte

Navn Betydning Karakter
Div yield, % 0 0
DSI 0 0
Total: 0

Plikt

Navn Betydning Karakter
Debt/EBITDA -0.0168 10
Total: 10

Vekstimpuls

Navn Betydning Karakter
Lønnsomhet Revenue, % -80.91 0
Lønnsomhet Ebitda, % 42.59 6
Lønnsomhet EPS, % -14.9 0
Total: 2.6
Flere detaljer

Institusjoner Volum Dele, %
Vanguard Group Inc 1392906 4.37
UBS Group AG 580578 1.82
Mission Wealth Management, LLC 501168 1.57
Laird Norton Trust Company, LLC 368835 1.16
Geode Capital Management, LLC 312472 0.98
Long Focus Capital Management, LLC 165701 0.52
Blackrock Inc. 156797 0.49
State Street Corporation 108500 0.34
Bank Of New York Mellon Corporation 96654 0.3
Susquehanna International Group, LLP 73303 0.23

ETF Dele, % Lønnsomhet for året, % Utbytte, %
iShares Micro-Cap ETF 0.02692 17.09 1.54048
Dimensional U.S. Core Equity 2 ETF 0.00005 30.76 1.47098



Veileder Stillingstittel Betaling Fødselsår
Dr. Amit Kumar Ph.D. CEO, Chairman & Co-Chair of CBAB 1.29M 1964 (61 år)
Mr. Michael J. Catelani CPA, MBA President, COO, CFO & Corporate Secretary 788.83k 1967 (58 år)
Mr. John Roop Senior Vice President of Engineering 275k 1950 (75 år)
Dr. Pamela D. Garzone Ph.D. Chief Development Officer & Chair Breast Cancer Clinical Advisory Board 1955 (70 år)

Adresse: United States, San Jose. CA, 3150 Almaden Expressway - åpne i Google maps, åpne Yandex-kart
Nettsted: https://www.anixa.com